Results 131 to 140 of about 1,816 (169)

New drugs: Asunaprevir [PDF]

Australian Prescriber, 2015
openaire   +1 more source

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination. [PDF]

BMC Med
Zarębska-Michaluk D, Brzdęk M, Tronina O, Janocha-Litwin J, Sitko M, Piekarska A, Klapaczyński J, Parfieniuk-Kowerda A, Sobala-Szczygieł B, Tudrujek-Zdunek M, Laurans Ł, Flisiak R.   +11 more
europepmc   +1 more source

Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response. [PDF]

Sci Rep
Chida T, Ohta K, Noritake H, Matsushita M, Murohisa G, Kageyama F, Sasada Y, Oyaizu T, Tsugiki M, Tamakoshi K, Nakajima T, Suda T, Kawata K.   +12 more
europepmc   +1 more source

Epidemiologic Characteristics of Chronic Hepatitis B and Coinfections with Hepatitis C Virus or Human Immunodeficiency Virus in South Korea: A Nationwide Claims-Based Study Using the Korean Health Insurance Review and Assessment Service Database. [PDF]

Pathogens
Oh H, Sohn W, Choi NR, Lee HY, Kim Y, Nam SW, Jeong JY.   +6 more
europepmc   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma. [PDF]

Ther Adv Gastroenterol
Nagaoki Y, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Ono A, Murakami E, Kawaoka T, Miki D, Aikata H, Hayes CN, Tsuge M, Oka S.   +12 more
europepmc   +1 more source

The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data. [PDF]

Pharmgenomics Pers Med
Wittwer NL, Meier CR, Huber CA, Moser JD, Meyer Zu Schwabedissen HE, Allemann SS, Schneider C.   +6 more
europepmc   +1 more source

Geometric Deep learning Prioritization and Validation of Cannabis Phytochemicals as Anti-HCV Non-nucleoside Direct-acting Inhibitors. [PDF]

Biomed Eng Comput Biol
Charles S, Edgar MP.
europepmc   +1 more source

Risk for Recurrence After Liver Resection in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Detected After Sustained Virological Response by Direct-Acting Antivirals: A Retrospective Multicenter Study. [PDF]

Cancers (Basel)
Tanaka S, Noda T, Komeda K, Yasuda S, Ueno M, Mori H, Kosaka H, Morimura R, Shinkawa H, Sekiguchi N, Ikoma H, Ishizawa T, Kaibori M.   +12 more
europepmc   +1 more source

Asunaprevir/daclatasvir

Reactions Weekly, 2017
core   +11 more sources